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Minocycline  suppresses  inﬂammatory  pain  irrespective  of  mouse  sex and  strain.
Lack  of motor  coordination  does  not  account  for  suppression  of nociceptive  response.
These  results  may  be translated  to minocycline’s  analgesic  actions  in  men  and  women.
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 18 July 2013
eceived in revised form 9 August 2013
ccepted 13 August 2013
eywords:
ex
ender
ice
a  b  s  t  r  a  c  t
The  research  on sex differences  in  nociception  and  antinociception  as well  as  sex  and  gender  differences
in  pain  and  analgesia  is a maturing  ﬁeld.  There  is a vast  literature  showing  experimental  and  clinical
pain  suppressive  effects  induced  by minocycline,  especially  in  inﬂammatory  pain.  However,  as  far  as  we
know,  possible  qualitative  or quantitative  sex  differences  in  those  effects  remained  to  be  examined.  By
employing  the formalin  test,  which  has  two  phases  of  experimental  pain  behavior  that  models  nociceptive
pain  (i.e., ﬁrst phase)  and  inﬂammatory  pain  (i.e.,  second  phase),  we  initially  evaluated  the  effect  induced
by minocycline  in female  or male  C57BL/6  mice.  The  treatment  reduced  the  second  phase  of  licking
behavior  in  both  females  and  males,  and  the effects  were  quantitatively  similar  in  both  sexes.  Likewise,etracyclines
ociception
ormalin test
the  same  sex-independent  effect  was observed  in  Swiss  mice,  suggesting  a genotype-unspeciﬁc  sex-
independent  effect.  While  minocycline  is  already  being  tested  in  clinical  trials,  this  appears  to be  the  ﬁrst
preclinical  investigation  of  sex differences  in  the  experimental  pain  suppressive  effects  induced  by  this
widely  studied  drug.  The  independence  of  sex in  the  antinociceptive  effect  induced  by minocycline  may
be  hopefully  translated  to  gender-independent  analgesic  effects,  which  would  be  surely  promising  in  a
therapeutic  paradigm.
. Introduction
Data from many studies show that pain/nociception and anal-
esia/antinociception, both in humans and experimental animals,
xhibit great interindividual variability and the factors that may
ontribute to such differences have been intensely investigated
ecently [18]. Furthermore, data from large epidemiological studies
learly show that pain is more prevalent in women than in men  [21].
evertheless, there is a clear male-orientated bias in experimental
ubject choice in the ﬁeld of pain and others; and the reasons for this
ias are believed to be the inertia of pain researchers and their over-
oncern about estrous cycle-related variability [18]. The inclusion
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of females is mandatory in clinical but not in preclinical studies. For
this reason, the awareness of this matter has been increasing and
the investigation of sex and gender differences in nociception, pain
and inﬂammation and their inhibition has been maturing [6,12].
Currently and more frequently, sex is used to refer to a biologically
based dichotomous variable, whereas gender refers to a socially
based phenomenon, considered to range from exclusively feminine
to exclusively masculine. Therefore, in human studies, group dif-
ferences are likely to be attributable to either sex or gender. On the
other hand, only the term “sex” applies to preclinical data and will
be used throughout this manuscript [12].
Clinical trials have been conducted to test the clinical utility of
repositioning minocycline as an analgesic or antirheumatic drug
[11,20,30]. Indeed, this second-generation tetracycline exhibits
anti-inﬂammatory effects unrelated to its antibacterial one [1], and
anti-inﬂammatory effects help explain either its antinociceptive [2]
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r neuroprotective actions [16,27]. Minocycline is neuroprotective
fter experimental stroke, a pathological condition characterized
y massive inﬂammatory response [29]. A study suggested that
he neuroprotective effect in the middle cerebral artery occlusion
odel is dependent on sex in C57BL/6 mice [19], whereas another
tudy suggested that neuroprotective effects in a thromboembolic
troke model are independent of sex in the same mouse strain [13].
herefore, we wondered whether there might be qualitative or
uantitative sex differences in the effect induced by minocycline
n inﬂammatory pain.
There is a very high number of studies showing suppression of
xperimental pain by tetracycline derivatives in rodents, especially
nﬂammatory pain [2]. However, as far as we know, just in a few
tudies the authors clearly informed the use of female animals only
3,24,32], and therefore a “head-to-head” comparison between the
ffects induced by minocycline in females and males remained to be
erformed. Then, we designed a straightforward study to compare
he effect induced by minocycline in female and male mice using
he formalin test, which models both nociceptive (i.e., ﬁrst phase
f licking behavior) and inﬂammatory (i.e., the second phase) pain
14,31]. To evaluate whether a sex difference is a genotype speciﬁc
r unspeciﬁc effect, we  evaluated the activity of minocycline in two
ouse strains.
. Materials and methods
.1. Animals
Seven to nine week-old C57BL/6 or Swiss mice of both sexes
ere used. Efforts were made to minimize both animal distress and
he number of animals used. The animals had free access to food
nd water and were maintained in a room with a 12 h light–dark
ycle. The experiments were performed at room with temperature
ontrolled between 26 and 28 ◦C, which ranges within the ther-
oneutral zone for mice [10] and it is suitable for carrying out
he temperature-sensitive formalin test [31]. All experiments were
erformed according to the ethical guidelines for the investiga-
ion of experimental pain in conscious animals [33]. Experimenters
ere blinded to treatments. Each experiment was  performed in a
eparate group of mice.
.2. Drugs
Minocycline hydrochloride (Galena, Campinas, Brazil),
ormaldehyde 37% (m/v) (Sigma–Aldrich, St Louis, MO,  USA)
nd phenobarbital (Aventis Pharma, São Paulo, Brazil) were used.
olutions and suspensions were prepared in isotonic saline imme-
iately before the intraperitoneal (i.p.) injections. The volume
njected was 5 ml/kg.
.3. Effect induced by minocycline on the nociceptive response
nduced by formalin in mice
For three consecutive days before the experiment, the ani-
als were habituated for approximately 30 min  to the testing
pparatuses to minimize stress-induced antinociception on the
esting day. Each mouse was placed under a transparent glass fun-
el (18 cm diameter, 15 cm high). Formalin (2.5%, v/v, 20 l) was
njected subcutaneously (s.c.) into the dorsum of the right hind
aw of mice 1 h after the i.p. administration of minocycline (12.5,
5, 50 or 100 mg/kg) or saline. This minocycline dose range was
hosen on the basis of previous studies performed by our research
roup and others [1,3–5,25]. The amount of time the animal inter-
ittently licked the injected paw was counted manually by usingetters 553 (2013) 110– 114 111
stopwatches between 0 and 5 min  (ﬁrst phase) and 15 and 30 min
(second phase) after the injection of formalin.
2.4. Evaluation of the motor coordination of mice in the rota-rod
The motor coordination of the animals was  evaluated in a rota-
rod apparatus. This test is essential when studying experimental
pain to examine the possibility of reduced display of nociceptive
behavior due to lack of motor coordination that may  result from
central nervous system depression or muscle relaxation [9,15].
The animals were trained on the apparatus for three days before
the experiment. On the testing day, the animals were placed on
the rotating rod (12 r.p.m.) and the latency to fall was  measured.
The cut-off time was  120 s. After conﬁrming that all animals were
sufﬁciently trained to stay on the rotating rod for at least 120 s,
they were treated with minocycline (100 mg/kg, i.p.) or pheno-
barbital (40 mg/kg; i.p., positive control) and 1 h later they were
again tested on the apparatus. Phenobarbital, a central nervous
system depressant, was  used as a positive control because of its
well-known ability to impair the performance of rodents in the
rotarod test [1,4,7].
2.5. Data analysis
The pain behavior data were analyzed by two-way ANOVA,
taking sex and drug treatment as main factors, followed by Bon-
ferroni post hoc test for multiple comparisons. Calculations of
half-maximal inhibitory doses (ID50) were performed by using
the software JFlashCalc (M.H. Ossipov, University of Arizona, AZ,
USA). As rota-rod data did not display normal distribution (ana-
lyzed by Kolmogorov–Smirnov test), Kruskal–Wallis test, followed
by Dunn’s multiple comparison test, was  applied. Values of p < 0.05
were considered to show signiﬁcant differences between means
or medians. The software Prism® 5 (GraphPad Software Inc., San
Diego, CA, USA) was  used for such analyses. For ease of reading,
the basic statistical values are shown in the text, whereas the more
extensive statistical information can be found in the ﬁgure captions.
3. Results
The s.c. injection of formalin (2.5%, 20 l) in mice induced a
biphasic nociceptive response characterized mainly by licking the
injected paw. Fig. 1A and 1B show that the ﬁrst phase of lick-
ing behavior was unaffected by minocycline treatment in C57BL/6
mice, whereas the second phase was  attenuated by this tetracy-
cline derivative, as revealed by two-way ANOVA. However, the
minocycline’s antinociceptive activity was  not affected by sex.
Reinforcing the sex-independent effect induced by minocycline in
this experimental setting, minocycline inhibited the second phase
of licking behavior in either female or age-matched male mice of
a different mouse strain (i.e., Swiss mice; Fig. 2B), whereas the
ﬁrst phase was unaffected (Fig. 2A). In male C57BL/6 and female
Swiss mice, the half-maximal inhibitory doses (ID50) were 89 mg/kg
(95% conﬁdence interval: 20–386 mg/kg) and 61 mg/kg (95% conﬁ-
dence interval: 24–155 mg/kg), respectively. By extrapolation, the
ID50 values in female C57BL/6 and male Swiss mice were 123
and 140 mg/kg, respectively; however, these estimated numbers
should be treated cautiously because the highest dose used in the
present study was 100 mg/kg (i.p.). We  have not tried higher doses
because of the risk of toxicity – 100 mg/kg is already a high dose.
Indeed, as far we know, there is no study on experimental pain that
used a dose of minocycline higher than 100 mg/kg (i.p.).Importantly, lack of motor coordination seems not to account for
reduced display of experimental pain behavior, as the highest dose
of minocycline (100 mg/kg) did not affect the performance of mice
in the rota-rod test (Table 1). On the other hand, phenobarbital, used
112 L.F.S. Bastos et al. / Neuroscience Letters 553 (2013) 110– 114
Fig. 1. Effects induced by minocycline (12.5, 25, 50 or 100 mg/kg or saline, i.p., −1 h) on the ﬁrst (A) and second (B) phase of nociceptive response induced by formalin in
female  or male C57BL/6 mice. (A) No effect of treatment on both sexes in the ﬁrst phase (p > 0.05). (B) Main effect of treatment, F(4,73) = 13.40, p < 0.0001; main effect of sex,
F(1,73) = 2.78, p = 0.1000; interaction, F(4,73) = 0.45, p = 0.7707. Data are expressed as mean ± SEM (n = 8–9), analyzed by two-way ANOVA followed by Bonferroni post hoc test,
taking treatment and sex as main factors. The Bonferroni test reveals no signiﬁcant statistical difference between females and males at any dose (all p values higher than
0.05).
Fig. 2. Effects induced by minocycline (12.5, 25, 50 or 100 mg/kg or saline, i.p., −1 h) on the ﬁrst (A) and second (B) phase of nociceptive response induced by formalin in
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bemale  or male Swiss mice. (A) No effect of treatment on both sexes (p > 0.05). (B) Ma
nteraction, F(4,71) = 0.68, p = 0.6059. Data are expressed as mean ± SEM (n = 8–9), ana
actors. The Bonferroni test reveals no signiﬁcant statistical difference between fem
s a positive control, inhibited the performance in comparison with
ehicle- or minocycline-treated animals.
. Discussion
Although the experimental pain suppressive effects induced by
inocycline have been widely studied [2], this seems to be the
rst study to examine possible sex differences in this context.
inocycline’s beneﬁcial actions on experimental inﬂammatory
nd neuropathic pain have been shown, but this drug seems
able 1
ffects induced by saline (vehicle), minocycline or phenobarbital (positive control) on the
Strain and sex Latency (s) to fall 1 h after the following treatments (i.p
Saline Mino 
25% Median 75% 25% 
C57BL/6 ♀ 111.0 120 120 64.5 
C57BL/6 ♂ 120 120 120 120 
Swiss ♀ 120 120 120 120 
Swiss  ♂ 120 120 120 120 
ata are expressed as median and 25% and 75% percentiles.
ut-off time and minimal baseline latencies to fall: 120 s
Signiﬁcantly different from respective saline-treated group medians (p < 0.05), as analyz
Signiﬁcantly different from respective minocycline-treated group medians (p < 0.05), as ct of treatment, F(4,71) = 12.28, p = 0.0001; main effect of sex, F(1,71) = 2.44, p = 0.1227;
 by two-way ANOVA followed by Bonferroni test, taking treatment and sex as main
nd males at any dose (all p values higher than 0.05).
not to suppress nociceptive pain. In the present study, we  show
that inﬂammatory pain is suppressed by minocycline in a sex-
independent manner in C57BL/6, the most widely used mouse
strain. We  used a second mouse strain (i.e., Swiss) and observed
similar results, thus reinforcing that the sex-independent effect
induced by minocycline is not restricted to a single mouse strain.
Indeed, the genotype makes difference when studying sex differ-
ences in pain. Because of this, some investigators fail to observe sex
differences that others document clearly, using robust statistical
analysis [22].
 motor coordination of female or male C57BL/6 or Swiss mice.
.)
100 mg/kg Pheno 40 mg/kg
Median 75% 25% Median 75%
120 120 6 19.5a,b 30.75
120 120 1 3a,b 35
120 120 3 5a,b 120
120 120 16 20a,b 120
ed by Kruskal–Wallis followed by Dunn’s multiple comparison tests. n = 7–9.
analyzed by Kruskal–Wallis followed by Dunn’s multiple comparison tests. n = 7–9.
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It is unlikely that central depression or muscle relaxation con-
ributed to the reduced nociceptive behavior displayed by the
nimals treated with minocycline, as this drug did not impair their
erformance in the rota-rod test, irrespective of mouse sex or
train. Similar results have also been observed for minocycline,
oxycycline [4] and 12S-hydroxy-1,12-pyrazolinominocycline (a
on-antibacterial minocycline derivative) [1] in previous studies.
sing the rota-rod test in a quite different experimental setting, it
as observed that minocycline reverses the impaired performance
f rats subjected to traumatic brain injury [28]. Although the rota-
od test is not very widely used in studies on experimental pain, its
se should be more strongly encouraged because it has proved to
e helpful in research involving screening of drugs that may  affect
otor coordination [9,15].
Sex differences in minocycline’s actions have been examined in
troke models, a pathological condition with a strong inﬂamma-
ory component [29], and somewhat contrasting results have been
hown. It was initially suggested that the neuroprotective effect in
he middle cerebral artery occlusion model is dependent on sex in
57BL/6 mice [19]. A more recent study suggested that this effect
nduced by minocycline on thromboembolic stroke is independent
f sex in the same mouse strain [13]. Different stroke models were
sed in these studies, which may  account for the observation of sex
ifference in one study but not in the other. However, in order to
ssess possible qualitative or quantitative sex differences related
o a certain drug treatment, dose-response curves should have
een built up in those studies instead of using a single dose, and
he curves for females and males statistically compared with each
ther. Therefore, this drawback might have led to misinterpretation
f sex differences in minocycline’s actions on experimental stroke,
nd this misleading data may  be counterproductive for transla-
ion from bench to bedside. Thus, appropriate pharmacological
pproaches and statistical analysis should be used rationally in such
tudies on sex differences to provide more reliable and conclusive
reclinical data.
The investigation of the inﬂuence exerted by sex on nocicep-
ion and antinociception in experimental animals is challenging as
any factors may  also be involved and contribute to erroneous
nterpretations. Many studies have shown that the animal strain
learly contributes to differences in the magnitude of experimen-
al pain [17] and also the experimental pain suppressive effects
nduced by many drugs [23]. Moreover, other factors, that have
een much less investigated, may  also affect the animal’s response.
mong them, season and time of the day affect the response of
nimals to a noxious stimulus, thus providing support to the impor-
ance of chronobiological factors in the modulation of experimental
ain [8,26].
Regarding the inﬂuence of sex on experimental pain, most of the
nvestigators aim to examine the neurochemical basis of the differ-
nces found in male and female rodents, particularly the inﬂuence
xerted by sex hormones [12], thus contributing to a better under-
tanding of pathophysiology of pain. However, when it comes to
he investigation of the effects induced by drugs (both experimen-
al and those at repositioning stage) on experimental pain, there
s a paucity of studies in which the authors examined their effects
n both sexes. Therefore, one can easily realize that the observa-
ion of similar effects induced by a drug on both male and female
xperimental animals is a positive aspect that may  contribute to
ranslation and pave the road to drug development or repositioning.
As far as we know, the present study is the ﬁrst preclinical
tudy to examine sex differences in the experimental pain sup-
ressive effects induced by a tetracycline derivative, and more
tudies are necessary for further elucidation of this matter. How-
ver, the demonstration of similar antinociceptive effects induced
y minocycline in both sexes of two mouse strains is a positive
esult that may  be hopefully translated to gender-independent
[
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analgesic effects, which would be promising in a clinical therapeu-
tic paradigm.
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